Photobiomodulation has FDA clearance for which treatment?

Photobiomodulation, often referred to as low-level laser therapy, is a treatment that utilizes specific wavelengths of light to promote healing and alleviate pain. The FDA has provided clearance for the use of photobiomodulation primarily for pain management in various conditions. This involves the application of light to targeted areas, which can help reduce inflammation, enhance cellular repair, and ultimately decrease pain sensation.

The other options, while potentially related to the benefits of photobiomodulation, are not specifically recognized by FDA clearance in the same way as pain management is. For instance, while increased healing rates can be an effect of photobiomodulation, the formal indication by the FDA centers around its effectiveness in managing pain, making it the correct choice in this context.